Implantable electroacupuncture system and method for reducing hypertension

• US 8,965,511 B2
• Filed: 08/29/2012
• Issued: 02/24/2015
• Est. Priority Date: 08/30/2011
• Status: Active Grant

• Current Assignee: Valencia Bioscience, Inc.
• Original Assignee: Valencia Technologies Corporation
• Inventors: Greiner, Jeffrey H., Peterson, David K. L., Thenuwara, Chuladatta
• Primary Examiner(s): Koharski, Christopher D
• Assistant Examiner(s): So, Elizabeth K
• Application Number:
  US13/598,582
• Publication Number:
  US 20140214115A1
• Time in Patent Office: 909 Days
• US Class Current: 607/44
• CPC Class Codes: A61H 39/002 Using electric currents electrotherapy A61N1/32
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362
• CPC Class Codes: A61N 1/36117 for treating hypertension
• CPC Class Codes: A61N 1/36125 Details of circuitry or electric components
• CPC Class Codes: A61N 1/36175 Pulse width or duty cycle
• CPC Class Codes: A61N 1/37205 Microstimulators, e.g. implantable through a cannula
• CPC Class Codes: A61N 1/37223 Circuits for electromagnetic coupling
• CPC Class Codes: A61N 1/375 Constructional arrangements, e.g. casings
• CPC Class Codes: A61N 1/3756 Casings with electrodes thereon, e.g. leadless stimulators
• CPC Class Codes: A61N 1/3758 Packaging of the components within the casing
• CPC Class Codes: A61N 1/3782 producing a voltage above the power source level
• CPC Class Codes: A61N 1/3787 from an external energy source
• CPC Class Codes: Y10T 29/49002 Electrical device making

Abstract

An implantable electroacupuncture device (IEAD) treats hypertension through application of stimulation pulses applied at at least one of acupoints PC5, PC6, LI4, ST36, ST37, LI11, LR3, and GB34. The IEAD comprises an implantable, coin-sized, self-contained, leadless electroacupuncture device having at least two electrodes attached to an outside surface of its housing. The device generates stimulation pulses in accordance with a specified stimulation regimen. Power management circuitry within the device allows a primary battery, having a high internal impedance, to be used to power the device. The stimulation regimen generates stimulation pulses during a stimulation session of duration T3 minutes applied every T4 minutes. The duty cycle, or ratio T3/T4, is very low, no greater than 0.05. The low duty cycle and careful power management allow the IEAD to perform its intended function for several years.

Claims

1. An Implantable ElectroAcupuncture System (IEAS) for treating hypertension comprising (a) at least one external component, and (b) a small, leadless, thin implantable component having a maximum linear dimension in a first plane of less than 25 mm, and a maximum linear dimension in a second plane orthogonal to the first plane of no more than 2.5 mm,

a. wherein the at least one external component comprises a magnetic field generator;

and

b. wherein the small, leadless, thin implantable component comprises

a housing made of a bottom part and a top part that are welded together to create an hermetically-sealed, thin, closed container, the top part and bottom part having respective top and bottom planar surfaces that are substantially parallel to each other and spaced apart by no more than 2.5 mm,

at least one feed-through terminal that passes through a portion of a wall of the top part or bottom part, and which allows electrical connection to be made between the inside of the closed container and a location on the outside of the closed container,

self-contained electronic circuitry inside of the closed container that, when enabled, generates stimulation pulses during a stimulation session, the stimulation session having a duration of T3 minutes, where T3 is at least 10 minutes, and wherein the electronic circuitry generates a new stimulation session at a rate of once every T4 minutes, where the ratio of T3/T4 is no greater than 0.05, wherein the stimulation pulses are coupled to the at least one feed-through terminal,

a sensor on the inside of the closed container adapted to sense the presence or absence of a magnetic field,

a power source inside of the closed container that provides operating power for the electronic circuitry, and

a symmetrical electrode configuration integrated into an outside surface of at least one of the top or bottom surfaces of the hermetically sealed container, the symmetrical electrode configuration comprising a symmetrical electrode configuration having a central electrode surrounded by an annular electrode, the central electrode having a surface area of at least 12.6 mm², and the spacing between the closest edges of the central electrode and annular electrode being at least 5 mm, at least one of the central electrode or the annular electrode being electrically connected to the at least one feed-through terminal, wherein a strong electric field gradient line is created in body tissue, when the implantable component of the IEAS is implanted in body tissue and the electronic circuitry is enabled, that extends perpendicularly out from the central electrode on which the electrode configuration resides, thereby directing the stimulation pulses contained in the stimulation sessions to a desired target tissue location located along the strong electric field gradient line, which desired target tissue location resides below the implantable component; and

c. wherein the at least one external component modulates a magnetic field which, when sensed by the sensor inside of the hermetically-sealed closed container, conveys information to the electronic circuitry inside of the closed container that controls when and how long the stimulation sessions are applied through the symmetrical electrode configuration.

2. The IEAS of claim 1 further including at least one recess in the top or bottom part of the small, thin housing where the at least one feed-through terminal passes through a portion of the wall of the top or bottom part, the recess providing thermal and mechanical isolation for the feed-through terminal from the high temperatures and residual weld stresses created when the top and bottom parts of the housing are welded together.

3. The IEAS of claim 2 wherein the central electrode of the symmetrical electrode configuration is located on the bottom surface of the hermetically-sealed closed container.

4. The IEAS of claim 3 wherein the annular electrode is located on the perimeter of the hermetically-sealed closed container.

5. The IEAS of claim 2 wherein the dimensions of the closed container are L×

W×

H, where L is the longest linear dimension, W is the shortest linear dimension measured in substantially the same plane as L, and H is the maximum height or thickness of the housing measured in a plane orthogonal with the plane where L and W are measured, and wherein L is no greater than about 25 mm, W is no less than about 15 mm and H is no greater than about 2.5 mm.

6. The IEAS of claim 2 wherein the power source comprises a primary battery having a nominal output voltage of no more than 3.0 volts and an internal impedance of no less than about 5 ohms.

7. The IEAS of claim 6 wherein the electronic circuitry inside of the closed container includes:

a boost converter circuit that boosts the nominal voltage of the primary battery to an output voltage V_OUT that is at least three times the nominal battery voltage;

a control circuit that selectively turns the boost converter circuit OFF and ON to limit the amount of current that may be drawn from the primary battery; and

an output circuit powered by V_OUT and controlled by the control circuit that generates the stimulation pulses during the stimulation session as defined by the specified stimulation regimen.

8. The IEAS of claim 7 wherein the stimulation pulses generated by the pulse generation circuit and delivered through the plurality of electrodes/arrays during the stimulation session comprise voltage pulses having a voltage amplitude of no less than about 1 V and no greater than about 15 V.

9. The IEAS of claim 7 wherein the stimulation pulses generated by the pulse generation circuit and delivered through the plurality of electrodes/arrays during a stimulation session comprise current pulses having a current amplitude of no less than about 1 milliampere (mA) and no greater than about 15 mA.

10. The IEAS of claim 9 wherein the primary battery has sufficient capacity to power the pulse generation circuitry in accordance with the specified stimulation regimen for a minimum of 2 years.

11. The IEAS of claim 7 wherein the duration of the stimulation session T3 varies between 10 minutes and 60 minutes and the rate of occurrence of the stimulation session T4 is set to a value between 1,440 minutes and 20,160 minutes.

12. The IEAS of claim 11 wherein the rate of occurrence of the stimulation session T4 is set to a value of at least 10,080 minutes.